# Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam

> **NCT03282370** · PHASE3 · COMPLETED · sponsor: **National Institute of Hygiene and Epidemiology, Vietnam** · enrollment: 655 (actual)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** JEVAX
- **BIOLOGICAL:** JECEVAX

## Key facts

- **NCT ID:** NCT03282370
- **Lead sponsor:** National Institute of Hygiene and Epidemiology, Vietnam
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-30
- **Primary completion:** 2018-02-06
- **Final completion:** 2018-04-08
- **Target enrollment:** 655 (ACTUAL)
- **Last updated:** 2018-09-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03282370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03282370, "Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03282370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*